A single injury, like a broken bone or a hard blow, has no convincing evidence behind it as a cause of cancer. What does have substantial evidence is the link between chronic, unresolved inflammation and cancer development. The distinction matters: it is not the initial damage that puts cells on a path toward malignancy, but rather what happens when the body’s healing response never fully shuts off. This idea dates back more than 150 years, and modern research has done a great deal to explain the biological machinery that makes it possible.
Why a Single Blow Does Not Cause Cancer
The belief that a single traumatic event can spark a tumor is surprisingly persistent, and it has a long history in courtrooms and popular culture. Lawsuits claiming that a fall, a car accident, or a sports collision caused someone’s cancer have been filed for over a century. A review in JAMA noted that such lawsuits are frequent, but also pointed out that falls are more often the result of a tumor than the cause of one: a bone weakened by an existing cancer may fracture during an ordinary stumble, leading the patient to believe the injury preceded the disease rather than the other way around.1JAMA. The Role of Trauma in Oncogenesis: A Juridical Consideration In other words, trauma draws attention to a cancer that was already there.
The epidemiological evidence backs this up. A systematic review of studies examining whether a single physical trauma causes cancer found that the data was sparse across nearly all cancer types. The only site with enough studies to pool was traumatic brain injury and brain cancer, and even there, cohort studies showed no meaningful increase in risk. Case-control studies suggested a modest association, but those study designs are more prone to recall bias, where people who develop cancer are more likely to remember and report past injuries than healthy people are.2CrossRef / SAGE Journals. Systematic review of the epidemiology of a single physical trauma and cancer The upshot is that if a single injury could reliably cause cancer, we would expect to see it clearly in large populations, and we simply do not.
Chronic Inflammation Is a Different Story
The German physician Rudolf Virchow was the first to propose, in the nineteenth century, that persistent low-grade inflammation might lead to cancer. That hypothesis has been corroborated by a large body of modern research.3PubMed. The contribution of Rudolf Virchow to the concept of inflammation: what is still of importance? The key word in Virchow’s idea is “persistent.” Normal inflammation is a tightly choreographed repair process: immune cells rush to the damaged area, clean up debris, kill invading microbes, and then gradually stand down as the tissue heals. Cancer risk rises when that stand-down phase fails.
The failure of inflammation to resolve is now recognized as a distinct pathway toward malignancy. When the healing program stays active for weeks, months, or years, the immune signals that were meant to be temporary become a permanent part of the tissue environment.4PubMed Central. Carcinogenesis: Failure of resolution of inflammation? A wide range of known carcinogens, including asbestos, tobacco smoke, and chronic alcohol exposure, appear to work partly by triggering inflammation that the body cannot properly shut off.4PubMed Central. Carcinogenesis: Failure of resolution of inflammation? The inflammation itself becomes the ongoing insult, regardless of whether the original cause is still present.
What Chronic Inflammation Does to Cells
Several biological processes run simultaneously in chronically inflamed tissue, and each one nudges cells closer to cancerous behavior.
Immune cells fighting a perceived threat produce reactive oxygen species, highly reactive molecules that can directly damage DNA. Under normal circumstances, the body’s repair systems fix most of this damage. But when the assault is continuous, errors slip through and accumulate.5PubMed Central. ROS and the DNA damage response in cancer Over time, these mutations can disable tumor-suppressor genes or activate genes that drive uncontrolled cell growth.
At the same time, the signaling environment in inflamed tissue actively encourages cells to survive and multiply. Two molecular switches in particular, known as NF-κB and STAT3, are chronically activated in many inflamed tissues. Together, they turn on genes that prevent damaged cells from dying and promote rapid cell division, exactly the combination a pre-cancerous cell needs to thrive.6PubMed Central. Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer
Chronic inflammation also reshapes the tissue surrounding the cells. Increased deposits of structural proteins like fibronectin create a stiff, fibrotic environment that resembles the dense tissue seen around many aggressive tumors. This remodeled scaffolding is associated with worse outcomes in cancers of the breast and pancreas, among others.7Nature Communications. Concepts of extracellular matrix remodelling in tumour progression and metastasis
Finally, chronically inflamed tissue tends to become immunosuppressive. That sounds paradoxical, but it happens because the immune system shifts from an attack posture to a tolerant one. Immune-suppressor cells accumulate, and the T cells that would ordinarily recognize and destroy abnormal cells are effectively switched off by checkpoint pathways.8PubMed Central. Immunosuppression associated with chronic inflammation in the tumor microenvironment A pre-cancerous cell arising in this environment faces far less resistance from the body’s normal defenses.
Marjolin’s Ulcer and Cancer in Chronic Wounds
One of the clearest examples of injury-related cancer is a condition called Marjolin’s ulcer, a malignant tumor that develops in a chronic wound or burn scar. The term originally referred to squamous cell carcinoma arising in burn scars, though it now covers any type of cancer that develops in a chronically non-healing wound.9PubMed Central. Retroauricular squamous cell carcinoma developing on a burn scar: Marjolin’s ulcer a case report and review of the literature The transformation typically takes years or even decades. A burn that heals poorly and keeps cycling through inflammation and partial repair creates exactly the kind of tissue environment described above: persistent DNA damage, constant cell turnover, and a remodeled structural landscape.10PubMed Central. Marjolin’s ulcers in the post-burned lesions and scars
Marjolin’s ulcers are rare, but they are aggressive when they do appear. They tend to be diagnosed late because the wound was already abnormal-looking, so changes in the tissue’s character are easy to miss.11PubMed Central. Marjolin ulcer: a rare clinical entity that every health professional should be informed about: a narrative review The lesson here is not that burns cause cancer in any routine sense, but that a wound that never completes the healing process can, over a long period, create conditions that favor malignant transformation.
Organ-Specific Examples of Inflammation-Driven Cancer
The chronic-inflammation pathway shows up across the body wherever tissue is repeatedly irritated.
The pancreas is a well-studied example. Chronic pancreatitis is one of the main risk factors for pancreatic cancer, though cancer still develops in only a small fraction of patients.12PubMed Central. Pancreatic Cancer in Chronic Pancreatitis: Pathogenesis and Diagnostic Approach A population-based cohort study found that patients with chronic pancreatitis who also had acute flare-ups faced roughly six times the risk of pancreatic cancer compared to the general population when followed for more than two years.13Scientific Reports. Incidence and risk of pancreatic cancer in patients with acute or chronic pancreatitis: a population-based cohort study The more frequently the pancreas is inflamed, the higher the risk, which fits the pattern of chronic damage outpacing repair.
Gallstone disease provides another window. Gallstones lodged in the gallbladder cause ongoing irritation and inflammation of the gallbladder wall. A Swedish cohort study found that people with gallstones who did not have their gallbladders removed had roughly two and a half times the risk of gallbladder cancer and double the risk of liver cancer at five or more years of follow-up, compared to the general population.14PubMed Central. Gallstones, cholecystectomy and risk of cancers of the liver, biliary tract and pancreas
In the esophagus and gut, chronic inflammatory conditions can also set the stage. Patients with inflammatory bowel disease who also had Barrett’s esophagus, a condition where the esophageal lining changes in response to chronic acid reflux, had about three times the odds of developing precancerous changes compared to patients with Barrett’s esophagus alone.15PubMed Central. Co-existing inflammatory bowel disease and Barrett’s esophagus is associated with esophageal dysplasia: a propensity score-matched cohort The combination of two inflammatory conditions in the same individual appeared to amplify the risk.
Foreign Bodies and Implant-Related Inflammation
An unusual but instructive line of evidence comes from foreign-body carcinogenesis, the development of cancer around materials the body cannot digest or break down. The foreign bodies themselves, whether metal, plastic, or other materials, are chemically unrelated to one another. What they share is the ability to provoke a chronic inflammatory response. Immune cells try to wall off or destroy the material, and when they fail, the resulting prolonged inflammation generates reactive oxygen species that can damage the DNA of surrounding cells.16PubMed. Beyond foreign-body-induced carcinogenesis: impact of reactive oxygen species derived from inflammatory cells in tumorigenic conversion and tumor progression
This has practical relevance for medical implants. Cancers arising near orthopedic hardware or other implanted devices are extremely rare, but when they occur, the proposed mechanism is chronic low-grade inflammation rather than any toxic property of the implant material itself. The body’s inability to resolve its immune response to the foreign object creates a microenvironment similar in principle to the one seen in chronic wounds.
Tumors as Wounds That Never Heal
In 1986, a researcher named Harold Dvorak described tumors as “wounds that do not heal,” and the analogy has proven remarkably durable. His work showed that tumor tissue captures blood-clotting proteins much faster than normal tissue, and the blood vessel growth factor driving this process, now called VEGF-A, turned out to be the same one that drives new blood vessel formation during wound repair.17Frontiers in Oncology. Contribution of Angiogenesis to Inflammation and Cancer Tumors and healing wounds share infiltrating immune cells, new blood vessel growth, and many of the same signaling molecules. The difference is that wound healing eventually stops; in a tumor, the process runs indefinitely.
Another parallel involves a process by which stationary skin cells gain the ability to migrate, normally a critical part of wound repair. During healing, the surface cells at the edge of a wound change their behavior so they can crawl across the wound bed and close the gap. Once the wound is sealed, these cells are supposed to revert to their normal state. In fibrosis and scarring, however, the cells that produce scar tissue are sometimes pathologically sustained instead of undergoing their normal shutdown.18PubMed Central. Epithelial-mesenchymal transition in tissue repair and fibrosis This same process of cells acquiring migratory behavior is a hallmark of cancer metastasis, and chronic tissue injury may push cells into a state where the transition toward mobility becomes permanent.
Research into regeneration and wound healing across species suggests that this overlap may represent an evolutionary trade-off. The capacity to repair damaged tissue requires many of the same cellular behaviors that drive tumor formation: rapid cell division, cell migration, new blood vessel growth, and local immune suppression. Species with greater regenerative capacity may face different cancer risks as a result.19Annual Review of Cancer Biology. Relationships Between Regeneration, Wound Healing, and Cancer
How Microbes Complicate the Picture
When tissue is injured, the microbial community living on or near it matters. The microbes that normally inhabit the gut, skin, and other surfaces are active regulators of the immune system. After an injury, changes in these microbial communities can either help calm inflammation or prolong it. Pathogenic microbes, or even commensal bacteria that find themselves in the wrong place after a wound, can chronically activate inflammatory pathways, alter the local tissue environment, and even produce substances that directly damage DNA.20PubMed Central. Microbiome, inflammation, and cancer
This is one reason why chronic infections at wound sites are considered a cancer risk factor in certain populations. Long-standing tropical ulcers, for instance, are among the chronic wounds that can give rise to Marjolin’s ulcers, and chronic infection of the wound is thought to be a major contributor. The microbes keep the immune system in a state of perpetual activation, and the resulting inflammatory damage accumulates over years.
Anti-Inflammatory Drugs and Cancer Prevention
If chronic inflammation truly drives certain cancers, then drugs that reduce inflammation should, in theory, lower cancer risk. That prediction has been borne out, most clearly with aspirin and other nonsteroidal anti-inflammatory drugs. Research over the past few decades has shown that regular NSAID use is associated with a reduced risk of several cancer types.21PubMed Central. Role of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Cancer Prevention and Cancer Promotion Aspirin in particular has been studied extensively, and the evidence that it can reduce both the incidence and mortality of certain cancers is considered strong enough that some researchers have advocated for its broader use in cancer prevention.22PubMed Central. Targeting Inflammation in Cancer Prevention and Therapy
The mechanism is not limited to blocking the classic inflammatory enzyme COX-2, which was the original focus of research. NSAIDs also appear to help resolve inflammation through additional pathways, potentially helping the body shut down the lingering immune activation that would otherwise persist in damaged tissue.23PubMed Central. NSAIDs and Cancer Resolution: New Paradigms beyond Cyclooxygenase That said, aspirin and other NSAIDs carry their own risks, including bleeding, so the decision to use them for cancer prevention involves weighing benefits against harms on an individual basis.
The anti-inflammatory evidence functions as a kind of reverse proof for the inflammation-cancer link. If reducing inflammation reduces cancer incidence, and if chronic inflammation creates the specific cellular conditions that favor tumor development, then the causal chain between persistent tissue injury and cancer becomes harder to dismiss as coincidence.
When Injury Unmasks Cancer Rather Than Causing It
A practical concern for anyone who develops cancer after an injury is the question of whether the injury caused the cancer or simply revealed it. This distinction, which was already a source of legal disputes by the early twentieth century, remains clinically relevant. A bone fracture that leads to imaging, which then reveals a tumor that was growing silently for months or years, is a case of detection rather than causation. The same is true for soft-tissue injuries that prompt medical visits during which a pre-existing lump is noticed for the first time.1JAMA. The Role of Trauma in Oncogenesis: A Juridical Consideration
This is especially easy to confuse with bone cancers and brain tumors. A pathological fracture, one that occurs because cancer has weakened the bone, can happen during a minor fall that would not break healthy bone. The patient understandably attributes the cancer to the fall, when in reality the cancer made the fall damaging in the first place. Clinicians evaluating these cases look at the timing, location, and type of cancer to distinguish between a cancer that was already present and one that might plausibly be linked to the injury.
The resolution of this question almost always points in one direction: the injury revealed the cancer. The biology of tumor development requires years of accumulated mutations and growth. A single traumatic event, however dramatic, does not compress that timeline. The rare exceptions, like cancers arising in chronically non-healing wounds, involve injury sustained over years or decades, not a single event.